Gastroenterology

In a new poster presented at the annual ACG meeting in San Antonio, researchers compare morbidity and mortality for ulcerative colitis patients with or without C. diff or CMV infections.

A new study presented at CHEST 2019 shows pulmonologists and ILD specialists will either reduce or temporarily interrupt antifibrotic care, depending on the form of adverse events a patient is experiencing.

Ustekinumab (Stelara) has received approval from the US Food and Drug Administration for the treatment of moderate to severely active ulcerative colitis in adults.

Data from a 961-patient study shows that ustekinumab can induce and maintain remission for patients with moderate-to-severe ulcerative colitis.

Investigators discover vedolizumab induces endoscopic remission in 33% of Crohn’s disease patients and histologic remission in 66% of patients after 52 weeks.

Recent measures in the UK has led to a drop in IBD patients using corticosteroids to excess.

In a new trial, investigators test whether continuing or discontinuing ADA is more beneficial.

The largest improvements for patients taking ustekinumab occurred following treatment every 8 weeks.

The AGA-approved guidelines call for a variety of different testing to better diagnose IBS-D in adults.

In the updated guidelines, investigators suggest direct-acting antivirals as the preferred treatment for hepatitis C viral infections in chronic kidney disease patients.

The FDA-approved drug targets IBS-C patients by increasing bowel movements, while lowering abdominal pain.

How patterns and trends in diet and lifestyle have influenced gastroenterology health.

Recent research advances have associated the gut's health to overall patient health. What do we know now?

Investigators find a gluten-free diet does not cause abdominal pain, reflux, indigestion, diarrhea, and constipation in non-gluten sensitive patients.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

After a 12-week study, investigators find a whole food diet, coupled with partial enteral nutrition, helps children with mild to moderate Crohn’s disease.

Robert G. Gish, MD, and the Global Liver Institute join up for a talk on all things hepatology.

In a new multivariable regression study, investigators link depression with a lack of social support and increased IBD activity.

A further examination of data from a research clinical database shows the risk of smoking outweigh any potential benefits for UC patients.

Early exposure to C. difficile helps infants stave off infection later in life.

Investigators find improved liver function in hepatocellular carcinoma patients tied to aspirin use in a new retrospective review.

New study identifies average cost and hospital length increase for hospital-acquired C. difficile.

Guidelines include combination of vaccines, screenings and case management to prevent hepatitis B from infecting infants.

New evidence from a cumulative RCT analysis suggests irritable bowel syndrome patients do not definitively benefit from FMT treatment.

The burdensome, inflammatory chronic condition is highlighted by difficult diagnoses and screening options. How is research advancing to improve care?